Gliclazid retard Zentiva 60 mg Tabletten
Gliclazid retard Zentiva 60 mg Tabletten is a medicine authorised by Swissmedic under authorisation number 65362. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 March 2015 and the authorisation is valid without a time limit. ATC code A10BB09 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 65362 |
|---|---|
| Name | Gliclazid retard Zentiva 60 mg Tabletten |
| Full name | Gliclazid retard Zentiva 60 mg Tabletten |
| Authorisation holder | Helvepharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BB09 |
| First authorisation | 03 March 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Gliclazid retard Zentiva 60 mg Tabletten | B | 03 March 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | A10BB09 | 07.06.2. | B |
| 2 | 90 | Tablette(n) | A10BB09 | 07.06.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Gliclazid retard Zentiva 60 mg Tabletten authorised in Switzerland?
Yes. Gliclazid retard Zentiva 60 mg Tabletten is authorised by Swissmedic under authorisation number 65362, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Gliclazid retard Zentiva 60 mg Tabletten have?
Gliclazid retard Zentiva 60 mg Tabletten is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Gliclazid retard Zentiva 60 mg Tabletten?
The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.